New pharmaceutical approaches to stroke prevention, treatment.
Phillips
P
P
D000925:Anticoagulants / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000517:prevention & control; D005060:Europe; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D018684:Glycine Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012106:Research
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D018684:Glycine Agents; D010975:Platelet Aggregation Inhibitors